Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HighLife Clarity Treatment of Severe Mitral Regurgitation

NCT06683729 is registered in ClinicalTrials.gov with HighLife SAS as lead sponsor.

NCT NCT06683729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HighLife Clarity Treatment of Severe Mitral Regurgitation
Lead sponsor
HighLife SAS
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 30, 2025
Completion date
June 30, 2034
Enrollment
240 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve (mv) regurgitation